Related Experiment Videos
Mucous membrane pemphigoid. Treatment experience at two institutions
P J Lamey1, T D Rees, W H Binnie
1Department of Oral Medicine, Glasgow Dental Hospital and School, Scotland.
Oral Surgery, Oral Medicine, and Oral Pathology
|July 1, 1992
Summary
Mucous membrane pemphigoid (MMP) often presents with oral lesions and can have extraoral manifestations. Topical steroids are effective treatments, but some patients require systemic therapy or other immunologically active drugs.
Area of Science:
- Oral pathology
- Dermatology
- Immunology
Background:
- Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease.
- Oral involvement is common in MMP, impacting patient quality of life.
Purpose of the Study:
- To present initial oral findings and treatment outcomes in 50 MMP cases.
- To correlate histologic and immunologic findings with clinical presentation and treatment response.
Main Methods:
- Clinical data collection from 50 patients diagnosed with MMP.
- Histologic examination of biopsies to confirm diagnosis.
- Immunologic studies to support clinical findings.
Main Results:
- Topical corticosteroids demonstrated efficacy in managing oral lesions.
- Systemic steroid therapy, sometimes combined with other immunomodulatory agents, was necessary for refractory cases.
- A significant proportion of patients exhibited extraoral manifestations alongside oral lesions.
Conclusions:
- MMP requires a tailored treatment approach based on disease severity and extent.
- Early diagnosis and appropriate management are crucial for controlling symptoms and preventing complications.
- The study highlights the importance of considering extraoral involvement in MMP patients.